Key facts
- Novartis Venture Fund is a other based in Basel, Switzerland with 23 tracked portfolio companies.
- Notable positions include Binx, Artios, Mediar Therapeutics.
About Novartis Venture Fund
Novartis Venture Fund is a direct investment firm based in Basel, Switzerland. Established in 1996, the firm prefers to invest in the life sciences, oncology, biotechnology, and digital health sectors. The assets are managed by the executive management team.
Free account
See more of the book
- ·The top 10 names in the book — of 23 recorded positions
- ·Watchlist + alerts for Novartis Venture Fund's activity
Create free account
No card required
Portfolio
23 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Binx | — | ▮ | ▮ | ▮ |
| Artios | Drug Discovery | ▮ | ▮ | ▮ |
| Mediar Therapeutics | — | ▮ | ▮ | ▮ |
+ 20 more companies · all 23, priced and dated or a free account shows the top 10 names — no card | ||||
Frequently asked
- What companies does Novartis Venture Fund invest in?
- Novartis Venture Fund has 23 recorded portfolio companies, including Binx, Artios, Mediar Therapeutics.
- What is Novartis Venture Fund's AUM?
- Novartis Venture Fund manages approximately $750 in assets.